Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Cancer immunotherapies based on WT-1 and gata-1 peptide epitopes

July 4, 2000

Cel-Sci receives permission to start phase II cancer trial in Canada

June 30, 2000

StressGen's HspE7 advances to phase III trials in anal dysplasia

June 28, 2000

FDA completes initial review of BLA for Campath

June 28, 2000

Lorus Therapeutics reports strong meta-analysis results for Virulizin, prepares for phase III trials

June 28, 2000

Tumor-associated antigen-derived immunogenic polypeptides useful for cancer immunotherapy

June 23, 2000

Mylotarg now available in U.S. as treatment for relapsed AML

June 22, 2000

Onyvax begins clinical trials for colorectal cancer vaccines

June 15, 2000

Immunomedics reports phase II results of CEA-Cide as colorectal cancer therapy

June 7, 2000

Progenics to continue GMK cancer vaccine trial as an extension study

June 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...